EverSource Wealth Advisors, LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1710537
BIRMINGHAM, AL
Position in SUPN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$251,159
+$10,016 QoQ
Shares Held
4,859
+0.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026EverSource Wealth Advisors, LLC holds $3,753,691 across 50 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
4,557 | $600,332 | |
| 2 | HLN |
Haleon plc
|
57,526 | $575,830 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
25,896 | $479,586 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
5,907 | $326,712 | |
| 5 | ZTS |
Zoetis Inc.
|
2,285 | $270,103 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
4,859 | $251,159 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
9,415 | $225,295 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
5,035 | $166,503 |
All Filings in SUPN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $251,159 | 4,859 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $241,143 | 4,852 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $67,717 | 1,417 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $51,439 | 1,632 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $723 | 20 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||